In contrast, when IL-13Rα2 was knocked-down prior to TSA therapy, the anti-tumor effect of combination of TSA and IL-13-PE was completely eliminated compared to mock vector transfected tumors, which showed dramatic tumor response (Figure 5B). Here, IL13 is linked to neoplasm.